Related MeSH Hierarchy (4)
Diseases [C] » Endocrine System Diseases [C19] » Diabetes Mellitus » Diabetes Complications » Diabetic Nephropathies
Diseases [C] » Urogenital Diseases [C12] » Female Urogenital Diseases and Pregnancy Complications » Female Urogenital Diseases » Urologic Diseases » Kidney Diseases » Diabetic Nephropathies
Diseases [C] » Urogenital Diseases [C12] » Male Urogenital Diseases » Urologic Diseases » Kidney Diseases » Diabetic Nephropathies
Diseases [C] » Urogenital Diseases [C12] » Urologic Diseases » Kidney Diseases » Diabetic Nephropathies
Description
KIDNEY injuries associated with diabetes mellitus and affecting KIDNEY GLOMERULUS; ARTERIOLES; KIDNEY TUBULES; and the interstitium. Clinical signs include persistent PROTEINURIA, from microalbuminuria progressing to ALBUMINURIA of greater than 300 mg/24 h, leading to reduced GLOMERULAR FILTRATION RATE and END-STAGE RENAL DISEASE. MeSH
Hierarchy View
Approved Indicated Drugs (6)
Phase 4 Indicated Drugs (48)
Phase 3 Indicated Drugs (17)
Phase 2 Indicated Drugs (48)
Phase 1 Indicated Drugs (5)
Other Experimental Indicated Drugs (18)
Organization Involved with Phase 4 Indications (56)
Aristotle University of Thessaloniki
Centro de Investigación Biomédica de Michoacán
Hospital General de Zona N° 83 Instituto Mexicano del Seguro Social.
Hospital General Regional N° 1 Instituto Mexicano del Seguro Social.
Huazhong University of Science and Technology
Organization Involved with Phase 3 Indications (71)
Gottfried Wilhelm Leibniz Universität Hannover
Grupo Medifarma, S. A. de C. V.
Hannover Clinical Trial Center GmbH
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Institut Universitaire de Recherche Clinique, RD Nephrologie SAS
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National University of Ireland
Postgraduate Institute of Medical Education and Research
The University of Texas, Dallas
Unidad de Investigacion Medica en Enfermedades Renales
Organization Involved with Phase 2 Indications (68)
Icahn School of Medicine at Mount Sinai
National Center for Complementary and Integrative Health (NCCIH)
Sanwa Kagaku Kenkyusho Co., Ltd.
South Texas Health Care System, San Antonio, TX
Organization Involved with Phase 1 Indications (18)
China Academy of Chinese Medical Sciences
Guangzhou Pharmaceucal Company Limited
Organization Involved with Other Experimental Indications (49)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
